Rezolve AI plc Enters Securities Purchase Agreements

TL;DR

Rezolve AI plc just signed new deals with investors on Sept 24, 2025.

AI Summary

On September 24, 2025, Rezolve AI plc entered into securities purchase agreements with certain investors. The company, formerly known as Rezolve AI Ltd and Rezolve Group Ltd, is based in London, United Kingdom.

Why It Matters

This filing indicates Rezolve AI plc is engaging in new financing activities, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — Entering into new securities purchase agreements can signal a need for capital, which may carry inherent risks for the company and its investors.

Key Players & Entities

• Rezolve AI plc (company) — Registrant
• September 24, 2025 (date) — Date of Purchase Agreements
• Rezolve AI Ltd (company) — Former Company Name
• Rezolve Group Ltd (company) — Former Company Name
• 21 Sackville Street, London, W1S 3DN United Kingdom (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $5.40 — ares ”), at an offering price of $5.40 per Ordinary Share. The Company intends
• $200 m — regate gross proceeds to the Company of $200 million, before deducting the placement a
• $3,000,000 — apply a credit to the Company equal to $3,000,000. In addition, the Company agreed to rei
• $120,000 — any agreed to reimburse A.G.P for up to $120,000 of its legal fees and other out-of-pock
• $10,000 — le expenses incurred by A.G.P for up to $10,000 in connection with the PIPE Financing.

Filing Documents

• second_closing_6-k.htm (6-K) — 45KB
• rzlv-ex10_1.htm (EX-10.1) — 347KB
• rzlv-ex10_2.htm (EX-10.2) — 84KB
• rzlv-ex10_3.htm (EX-10.3) — 277KB
• 0001193125-25-220703.txt ( ) — 754KB

From the Filing

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number 001-42254 Rezolve AI plc (Translation of registrant’s name into English) 21 Sackville Street, London, W1S 3DN United Kingdom (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F  Form 40-F  INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K Securities Purchase Agreements On September 24, 2025, Rezolve AI plc (the “ Company ”) entered into securities purchase agreements (the “ Purchase Agreements ”) with certain investors (the “ Purchasers ”) pursuant to which the Company agreed to sell and issue to the Purchasers in a private placement offering (the “ PIPE Financing ”) 37,000,000 ordinary shares, par value 0.0001 per share (the “ Ordinary Shares ”), at an offering price of $5.40 per Ordinary Share. The Company intends to use the net proceeds of the PIPE Financing for accelerated investment into its sales organization, potential accretive M&A opportunities, working capital and general corporate purposes, including further development of its Brain Commerce Platform, and expansion of Visual Search and Brain Checkout. A.G.P/Alliance Global Partners (“ A.G.P ”) acted as a placement agent in connection with the PIPE Financing. The Ordinary Shares are being offered pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”) and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. Pursuant to the Purchase Agreements, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed issuance of any Ordinary Shares or Ordinary Share equivalents, or file any registration statement or any amendment or supplement thereto, for a period of 60 days after the date the Initial Registration Statement (as defined below) has been declared effective by the Securities and Exchange Commission, subject to certain exceptions. The PIPE Financing closed on September 25, 2025, resulting in aggregate gross proceeds to the Company of $200 million, before deducting the placement agent’s fee and offering expenses payable by the Company. Placement Agent Agreement The Company also entered into a Placement Agent Agreement (the “ Placement Agent Agreement ”) with A.G.P., dated September 24, 2025, pursuant to which A.G.P agreed to serve as placement agent for the Company in connection with the PIPE Financing. The Company agreed to pay A.G.P a cash fee equal to 6.0% of the gross cash proceeds received in the PIPE Financing; however, A.G.P. agreed to apply a credit to the Company equal to $3,000,000. In addition, the Company agreed to reimburse A.G.P for up to $120,000 of its legal fees and other out-of-pocket expenses in connection with the PIPE Financing as well as non-accountable expenses incurred by A.G.P for up to $10,000 in connection with the PIPE Financing. Pursuant to the Placement Agent Agreement, the Company shall be subject to securities issuance restrictions as described in the Purchase Agreements The Placement Agent Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties, and termination provisions. Registration Rights Agreement Concurrently with the Purchase Agreements and the Placement Agent Agreement, on September 24, 2025, the Company and the Purchasers entered into a Registration Rights Agreement (the “ Registration Rights Agreement ”) pursuant to which the Company agreed to file a registration statement (the “ Initial Registration Statement ”) providing for the resale of the Ordinary Shares within 3 business days following the closing of the PIPE Financing, to have such registration statement declared effective with 30 days of the filing date (or 60 days, if the Securities and Exchange Commission conducts a full review), and to maintain the effectiveness of such registration statement. The foregoing summaries of the Purchase Agreements, the Placement Agency Agreement, and the Registration Rights Agreement, do not purport to be complete and are qualified in their entirety by reference to the complete text of those agreements, which are attached hereto as Exhibits 10.1, 10.2, and 10.3 respectively, to this Report of Foreign Private Issuer on Form 6-K and are incorporated herein by reference. The information included in this Report on Form 6-K (including Exhib

View Full Filing

View this 6-K filing on SEC EDGAR